Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way. 

During a government-regulated lockdown in Argentina, patients admitted to the emergency department were much more likely to have high blood pressure. 

Treatment with empagliflozin for six months was associated with several key improvements. This suggests that, yes, SGLT2 inhibitors can be recommended for HFrEF patients who don't have diabetes. 

“These observations support rigorous adherence to COVID-19 prevention strategies in obese individuals of all ages,” the researchers wrote. 

Transcatheter tricuspid valve repair consistently led to improved outcomes for patients with tricuspid regurgitation.

The analysis, published in the British Journal of Nutrition, included more than 8,000 adults.

Specialists from the American College of Cardiology and Society of Thoracic Surgeons explored data from more than 276,000 patients who have undergone a TAVR procedure in the last nine years. 

The American Medical Association has adopted new telehealth policy positions, the organization announced upon the Tuesday closing of a special five-day virtual meeting. 

Despite those similarities, EVALI and the novel coronavirus require very different treatments.